| Literature DB >> 29376491 |
Changping Zheng1, Marco Terreni2, Matthieu Sollogoub1, Yongmin Zhang1,3.
Abstract
Ganglioside GM3 is strongly related with human tumors, such as lung, brain cancers and melanomas, and more and more evidences have revealed that GM3 possesses powerful effects on cancer development and progression. GM3 is over expressed on several types of cancers, and can be as a tumor-associated carbohydrate antigen, used for immunotherapy of cancers. GM3 can also inhibit tumor cells growth by anti-angiogenesis or motility and so on. Especially, GM3 has effects on the EGFR tyrosine kinase signaling, uPAR-related signaling and glycolipid-enriched microdomains, which are essential for cancer signaling conduction. It is obvious that GM3 will be a promising target for cancer treatment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: EGFR; GM3; GM3-enriched microdomains; anti-angiogenesis; antitumor; cell motility; immunotherapy; uPAR-related signaling.
Mesh:
Substances:
Year: 2019 PMID: 29376491 DOI: 10.2174/0929867325666180129100619
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530